IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

Approximately 3% of the world population is chronically infected with the hepatitis C virus (HCV), with potential development of cirrhosis and hepatocellular carcinoma. Despite the availability of new antiviral agents, treatment remains suboptimal. Genome-wide association studies (GWAS) identified r...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 210; no. 6; pp. 1109 - 1116
Main Authors Bibert, Stéphanie, Roger, Thierry, Calandra, Thierry, Bochud, Murielle, Cerny, Andreas, Semmo, Nasser, Duong, François H T, Gerlach, Tilman, Malinverni, Raffaele, Moradpour, Darius, Negro, Francesco, Müllhaupt, Beat, Bochud, Pierre-Yves
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 03.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Approximately 3% of the world population is chronically infected with the hepatitis C virus (HCV), with potential development of cirrhosis and hepatocellular carcinoma. Despite the availability of new antiviral agents, treatment remains suboptimal. Genome-wide association studies (GWAS) identified rs12979860, a polymorphism nearby IL28B, as an important predictor of HCV clearance. We report the identification of a novel TT/-G polymorphism in the CpG region upstream of IL28B, which is a better predictor of HCV clearance than rs12979860. By using peripheral blood mononuclear cells (PBMCs) from individuals carrying different allelic combinations of the TT/-G and rs12979860 polymorphisms, we show that induction of IL28B and IFN-γ-inducible protein 10 (IP-10) mRNA relies on TT/-G, but not rs12979860, making TT/-G the only functional variant identified so far. This novel step in understanding the genetic regulation of IL28B may have important implications for clinical practice, as the use of TT/G genotyping instead of rs12979860 would improve patient management.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Members of the Swiss Hepatitis C Cohort Study group are listed in the appendix.
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.20130012